Avid Bioservices Inc (NASDAQ:CDMO)
| 31.56 Delayed Data As of Nov 26 |  -0.015 / -0.05%Today’s Change | 8.52 Today|||52-Week Range 34.51 | +173.44% Year-to-Date |
Latest CDMO News | Press Releases
| Avid Bioservices (CDMO) Earnings Expected to Grow: What to Know Ahead of Q2 Release Nov 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 31.57 |
| Today’s open | 31.20 |
| Day’s range | 30.88 - 32.35 |
| Volume | 17,560 |
| Average volume (3 months) | 782,102 |
| Market cap | $1.9B |
Data as of 1:00pm ET, 11/26/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +283.33% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +60.58% |
| P/E ratio | 315.6 |
| Price/Sales | 13.27 |
| Price/Book | 24.70 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DVAXDynavax Technologies... | -0.05 | -0.31% |
| NSTGNanoString Technolog... | -0.93 | -2.18% |
| SRNESorrento Therapeutic... | -0.02 | -0.34% |
| MORFMorphic Holding Inc | -2.80 | -5.43% |
Data as of 1:00pm ET, 11/26/2021
Financials
| Next reporting date | December 13, 2021 |
| EPS forecast (this quarter) | $0.03 |
| Annual revenue (last year) | $95.9M |
| Annual profit (last year) | $11.2M |
| Net profit margin | 11.70% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Tustin, California |
Forecasts
